Search Results - Muccino, David R.

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough

    Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough by Muccino, David R, Morice, Alyn H, Birring, Surinder S, Dicpinigaitis, Peter V, Pavord, Ian D, Assaid, Christopher, Kleijn, Huub Jan, Hussain, Azher, La Rosa, Carmen, McGarvey, Lorcan, Smith, Jaclyn A

    Published in ERJ open research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

    Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, rando... by McGarvey, Lorcan P, Birring, Surinder S, Morice, Alyn H, Dicpinigaitis, Peter V, Pavord, Ian D, Schelfhout, Jonathan, Nguyen, Allison Martin, Li, Qing, Tzontcheva, Anjela, Iskold, Beata, Green, Stuart A, Rosa, Carmen La, Muccino, David R, Smith, Jaclyn A

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks

    Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks by Birring, Surinder S, Dicpinigaitis, Peter V, Smith, Jaclyn A, Morice, Alyn H, McGarvey, Lorcan P, Pavord, Ian D, Nguyen, Allison Martin, Schelfhout, Jonathan, Li, Qing, Iskold, Beata, Green, Stuart A, Philip, George, Muccino, David R, La Rosa, Carmen

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant

    Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant by Morice, Alyn H., Birring, Surinder S., Smith, Jaclyn A., McGarvey, Lorcan P., Schelfhout, Jonathan, Martin Nguyen, Allison, Xu, Zhi Jin, Wu, Wen-Chi, Muccino, David R., Sher, Mandel R.

    Published in Lung
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough

    Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough by Schelfhout, Jonathan, Nguyen, Allison Martin, Birring, Surinder S., Bacci, Elizabeth D., Vernon, Margaret, Muccino, David R., La Rosa, Carmen, Smith, Jaclyn A.

    Published in Lung
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Efficacy and safety of gefapixant, a P2X 3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

    Efficacy and safety of gefapixant, a P2X 3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, rand... by McGarvey, Lorcan P, Birring, Surinder S, Morice, Alyn H, Dicpinigaitis, Peter V, Pavord, Ian D, Schelfhout, Jonathan, Nguyen, Allison Martin, Li, Qing, Tzontcheva, Anjela, Iskold, Beata, Green, Stuart A, Rosa, Carmen La, Muccino, David R, Smith, Jaclyn A

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Evaluation of Cough Triggers Among Responders and Non-Responders of Treatment with MK-7264, a P2X3 Receptor Antagonist

    Evaluation of Cough Triggers Among Responders and Non-Responders of Treatment with MK-7264, a P2X3 Receptor Antagonist by Sher, Mandel R., Birring, Surinder, Smith, J., McGarvey, L., Morice, Alyn H., Wu, Wen-Chi, Xu, Jin, Muccino, David

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: